Table of Contents Author Guidelines Submit a Manuscript
Emergency Medicine International
Volume 2017 (2017), Article ID 4235785, 5 pages
https://doi.org/10.1155/2017/4235785
Research Article

Tranexamic Acid (TXA) in Trauma Patients: Barriers to Use among Trauma Surgeons and Emergency Physicians

Department of Emergency Medicine, University of Maryland Shore Regional Health, Easton, MD, USA

Correspondence should be addressed to Abdulaziz Alburaih; moc.liamg@hiarublaziza

Received 17 September 2016; Revised 1 December 2016; Accepted 22 January 2017; Published 20 February 2017

Academic Editor: Joe Nemeth

Copyright © 2017 Abdulaziz Alburaih. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Objective. Tranexamic Acid (TXA) is currently the only drug with prospective clinical evidence supporting its use in bleeding trauma patients. We sought to better understand the barriers preventing its use and elicit suggestions to further its use in trauma patients in the state of Maryland. Methods. This is a cross-sectional study. Results. The overall response rate was 38%. Half of all participants reported being familiar with the CRASH-2 trial and MATTERs study. Half reported being aware of TXA as part of their institution’s massive transfusion protocol. The majority of participants felt that TXA would have a significant positive impact on the survival of trauma patients. A majority also felt that the use of TXA would increase if its administration was the responsibility of both trauma surgeons and emergency physicians. Conclusion. Only half of responders reported being aware of TXA as being part of their institution’s massive transfusion protocol. Lack of awareness of the clinical data supporting its use is a major barrier. However, most trauma providers and emergency physicians do have a favorable view of TXA and support its incorporation into massive transfusion protocols. We believe that more studies of this kind on both state and national level are needed.